These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18929631)

  • 1. Spray drying of budesonide, formoterol fumarate and their composites--I. Physicochemical characterisation.
    Tajber L; Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2009 Feb; 367(1-2):79-85. PubMed ID: 18929631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spray drying of budesonide, formoterol fumarate and their composites-II. Statistical factorial design and in vitro deposition properties.
    Tajber L; Corrigan OI; Healy AM
    Int J Pharm; 2009 Feb; 367(1-2):86-96. PubMed ID: 18929634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can low-dose combination products for inhalation be formulated in single crystalline particles?
    Kumon M; Kwok PC; Adi H; Heng D; Chan HK
    Eur J Pharm Sci; 2010 Apr; 40(1):16-24. PubMed ID: 20172026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery.
    Nolan LM; Tajber L; McDonald BF; Barham AS; Corrigan OI; Healy AM
    Eur J Pharm Sci; 2009 Jul; 37(5):593-602. PubMed ID: 19463948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.
    da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG
    Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered mucoadhesive microparticles of formoterol/budesonide for pulmonary administration.
    Monou PK; Andriotis EG; Bouropoulos N; Panteris E; Akrivou M; Vizirianakis IS; Ahmad Z; Fatouros DG
    Eur J Pharm Sci; 2021 Oct; 165():105955. PubMed ID: 34298141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine.
    Najafabadi AR; Gilani K; Barghi M; Rafiee-Tehrani M
    Int J Pharm; 2004 Nov; 285(1-2):97-108. PubMed ID: 15488683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid budesonide microparticles for controlled release inhalation therapy.
    Mezzena M; Scalia S; Young PM; Traini D
    AAPS J; 2009 Dec; 11(4):771-8. PubMed ID: 19908147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of process variables on the micromeritic and physicochemical properties of spray-dried microparticles--Part II. Physicochemical characterisation of spray-dried materials.
    Paluch KJ; Tajber L; Amaro MI; Corrigan OI; Healy AM
    J Pharm Pharmacol; 2012 Nov; 64(11):1583-91. PubMed ID: 23058045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable sugar-based protein formulations by supercritical fluid drying.
    Jovanović N; Bouchard A; Sutter M; Van Speybroeck M; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
    Int J Pharm; 2008 Jan; 346(1-2):102-8. PubMed ID: 17659851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethiazide.
    Healy AM; McDonald BF; Tajber L; Corrigan OI
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1182-6. PubMed ID: 18595674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of Inhalable Solid Dosage Forms of Budesonide and Theophylline for Pulmonary Combination Therapy.
    Leng D; Kissi EO; Löbmann K; Thanki K; Fattal E; Rades T; Foged C; Yang M
    AAPS PharmSciTech; 2019 Mar; 20(3):137. PubMed ID: 30847607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions.
    Dontireddy R; Crean AM
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1141-9. PubMed ID: 21615280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and quantification of amorphous material in milled and spray-dried salbutamol sulfate: a comparison of thermal, spectroscopic, and water vapor sorption approaches.
    Grisedale LC; Jamieson MJ; Belton P; Barker SA; Craig DQM
    J Pharm Sci; 2011 Aug; 100(8):3114-3129. PubMed ID: 21456029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation.
    Kubavat HA; Shur J; Ruecroft G; Hipkiss D; Price R
    Int J Pharm; 2012 Jul; 430(1-2):26-33. PubMed ID: 22449413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate.
    Shariare MH; de Matas M; York P
    Int J Pharm; 2011 Aug; 415(1-2):62-72. PubMed ID: 21683128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.